Catalyst Wire Dossier Catalyst Wire Dossier

ANCOBON

Flucytosine · Bausch Health US LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ANCOBON, covering 2006-08-10 to 2022-02-15. Get the full timeline:

Most recent: FDA Approved: ANCOBON — Supplemental Application (Bausch Health US LLC)

See pricing